{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:18:06Z","timestamp":1787699886140,"version":"build-2784847793"},"reference-count":25,"publisher":"Georg Thieme Verlag KG","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pneumologie"],"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Die Tabakindustrie hat in der Vergangenheit ihre Produktstrategie wiederholt angepasst. Sobald sich die Gesundheitssch\u00e4dlichkeit des Tabakkonsums nicht mehr leugnen lie\u00df, reagierte sie mit \u00f6ffentlichkeitswirksamen Kampagnen, die wissenschaftliche Erkenntnisse relativieren sollten. Zus\u00e4tzlich sollten modifizierte Produkte wie Zigarettenfilter oder sog. \u201eLight\u201c-Zigaretten den Anschein einer reduzierten Sch\u00e4dlichkeit vermitteln. Diese Strategie war in letzter Zeit immer weniger erfolgreich. Verh\u00e4ltnispr\u00e4ventive Gesundheitspolitik hat im Kontext mit der gestiegenen Aufkl\u00e4rung der Bev\u00f6lkerung einen weltweiten R\u00fcckgang des Tabakkonsums bewirkt. Mit neuen Nikotinprodukten wie E-Zigaretten, Tabakerhitzern und Nikotinbeuteln wird nun ein zus\u00e4tzliches Marktsegment entwickelt, das den r\u00fcckl\u00e4ufigen Kernmarkt erg\u00e4nzt. Und wiederum wird die mit dem Suchtmechanismus verbundene Gesundheitssch\u00e4dlichkeit als \u201eharm reduction\u201c relativiert. Neue Produkte werden als therapeutische Hilfsmittel f\u00fcr den Rauchstopp umgedeutet, womit sich die Tabakindustrie den Anschein pharmazeutischer Unternehmen geben will. Gleichzeitig wird mit einer Doppelstrategie der Kernmarkt mit Tabakprodukten weitergef\u00fchrt, wobei dieses Produktsegment in absehbarer Zukunft den dominanten Anteil von Umsatz und Gewinn behalten wird. Insofern passt sich die Tabakindustrie den neuen Verh\u00e4ltnissen an, ohne das auf Nikotinabh\u00e4ngigkeit beruhende Gesch\u00e4ftsmodell zu verlassen.<\/jats:p>","DOI":"10.1055\/a-2847-7259","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:52:32Z","timestamp":1787698352000},"source":"Crossref","is-referenced-by-count":0,"title":["Erfindet sich die Tabakindustrie neu?"],"prefix":"10.1055","author":[{"given":"Wulf","family":"Pankow","sequence":"additional","affiliation":[{"name":"Philipps-Universit\u00e4t Marburg, Fachbereich Medizin, Marburg, Deutschland"},{"name":"Vivantes Institut f\u00fcr Nikotin- und Tabakentw\u00f6hnung, Berlin, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Vitzthum","sequence":"additional","affiliation":[{"name":"Vivantes Institut f\u00fcr Nikotin- und Tabakentw\u00f6hnung, Berlin, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Sommer","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik II, Universit\u00e4tsklinikum Gie\u00dfen, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Hanewinkel","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Therapie- und Gesundheitsforschung, IFT-Nord gGmbH, Kiel, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Andreas","sequence":"additional","affiliation":[{"name":"Lungenfachklinik Immenhausen, Immenhausen, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"ref3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1136\/tc.2005.012336","article-title":"German tobacco industry\u02bcs successful efforts to maintain scientific and political respectability to prevent regulation of secondhand smoke","volume":"15","author":"A Bornh\u00e4user","year":"2006","journal-title":"Tob Control"},{"key":"ref4","first-page":"A770","article-title":"Tabakindustrie und \u00c4rzte: \u201eVom Teufel bezahlt\u200a\u2026\u201c","volume":"104","author":"T Gr\u00fcning","year":"2007","journal-title":"Dtsch Arztebl"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1055\/a-2867-9991","article-title":"Neue Nikotinprodukte: Zuk\u00fcnftige Verbreitung und Konsequenzen f\u00fcr die Pr\u00e4vention","author":"W Pankow","year":"2026","journal-title":"Pneumologie"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1055\/a-2508-1456","article-title":"Interessengesteuertes Framing: Die Sprache der Nikotinindustrie [Interest-driven framing: the language of the nicotine industry]. German","volume":"80","author":"W Posch","year":"2026","journal-title":"Pneumologie"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.7326\/M17-0759","article-title":"The Pharmaceuticalization of the Tobacco Industry","volume":"167","author":"Y H Hendlin","year":"2017","journal-title":"Ann Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"A73","DOI":"10.18332\/tid\/111616","article-title":"Does iQOS harvest personal data from users and manipulate their tobacco habits? A review of current evidence","volume":"17","author":"K Przewozniak","year":"2019","journal-title":"Tobacco Induced Diseases"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2301808","DOI":"10.1183\/13993003.01808-2023","article-title":"European Respiratory Society statement on novel nicotine and tobacco products, their role in tobacco control and \u201charm reduction\u201d","volume":"63","author":"D T Chen","year":"2024","journal-title":"Eur Respir J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/tc.10.4.300","article-title":"Germany: tobacco industry paradise","volume":"10","author":"M Poetschke-Langer","year":"2001","journal-title":"Tob Control"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/tc.2005.015347","article-title":"The Tobacco Control Scale: a new scale to measure country activity","volume":"15","author":"L Joossens","year":"2006","journal-title":"Tob Control"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jama.1995.03530030045033","article-title":"Nicotine and addiction. The Brown and Williamson documents","volume":"274","author":"J Slade","year":"1995","journal-title":"JAMA"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2105\/AJPH.2004.061507","article-title":"Tobacco industry influence on science and scientists in Germany","volume":"96","author":"T Gr\u00fcning","year":"2006","journal-title":"Am J Public Health"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(02)11262-1","article-title":"Continuing influence of tobacco industry in Germany","volume":"360","author":"A Gilmore","year":"2002","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(02)08275-2","article-title":"Tobacco industry strategies for influencing European Community tobacco advertising legislation","volume":"359","author":"M Neuman","year":"2002","journal-title":"Lancet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1024\/suc.2001.47.2.104","article-title":"Auswirkungen eines totalen Werbeverbots f\u00fcr Tabakprodukte \u2013 ein Diskussionsbeitrag","volume":"47","author":"R Hanewinkel","year":"2001","journal-title":"Sucht"},{"key":"ref30","volume-title":"Ursachen gesundheitlichen Fehlverhaltens im Jugendalter: Eine empirische Analyse am Beispiel des Zigarettenkonsums \u2013 Einstieg und Gewohnheitsbildung","author":"R Bergler","year":"1995"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1136\/tc.2005.012336","article-title":"German tobacco industry\u02bcs successful efforts to maintain scientific and political respectability to prevent regulation of secondhand smoke","volume":"15","author":"A Bornh\u00e4user","year":"2006","journal-title":"Tob Control"},{"key":"ref32","first-page":"61","article-title":"Exposure of Children and Adolescents to Passive Smoking in Cars","volume":"123","author":"R Hanewinkel","year":"2026","journal-title":"Dtsch Arztebl International"},{"key":"ref33","first-page":"206","article-title":"Smoking Cessation in Patients with COPD","volume":"77","author":"S Andreas","year":"2023","journal-title":"Pneumologie"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jama.2022.0395","article-title":"Treatment of Tobacco Smoking: A Review","volume":"327","author":"N A Rigotti","year":"2022","journal-title":"JAMA"},{"key":"ref35","first-page":"341","article-title":"Smoking cessation in hospitalised patients \u2013 Initiate among inpatients, continue when outpatients \u2013 A Position Paper by the German Respiratory Society (DGP) Taskforce for Smoking Cessation]","volume":"77","author":"M Raspe","year":"2023","journal-title":"Pneumologie"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1055\/a-2819-344","article-title":"Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution \u2013 Information from Section E3 of the DGP regarding the G-BA Resolution","author":"K F Franzen","year":"2026","journal-title":"Pneumologie"},{"key":"ref37","first-page":"612","article-title":"Implementation of smoking cessation in the workflow of a lung cancer screening program in Germany \u2013 A Position Paper of the German Respiratory Society (DGP)","volume":"78","author":"A Rupp","year":"2024","journal-title":"Pneumologie"},{"key":"ref38","first-page":"9","article-title":"Tobacco control in Germany and the role of the German Society of Pneumology (DGP)","volume":"61","author":"R Loddenkemper","year":"2007","journal-title":"Pneumologie"},{"key":"ref39","first-page":"320","article-title":"Medical societies in Germany call for a ban on flavors in e-cigarettes \u2013 A Position Paper of the German Respiratory Society (DGP) in cooperation with other professional associations and organizations])","volume":"78","author":"A Rupp","year":"2024","journal-title":"Pneumologie"},{"key":"ref40","first-page":"473","article-title":"German Respiratory Society Position Statement: Recommondations for handling electronic cigarettes (e-cigarettes)","volume":"76","author":"Deutsche Gesellschaft fur Pneumologie und Beatmungsmedizin in Zusammenarbeit mit medizinischen Fachgesellschaften und Organisationen: Deutsche Gesellschaft fur Innere Medizin","year":"2022","journal-title":"Pneumologie"}],"container-title":["Pneumologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2847-7259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:52:34Z","timestamp":1787698354000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2847-7259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":25,"URL":"https:\/\/doi.org\/10.1055\/a-2847-7259","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0934-8387","1438-8790"],"issn-type":[{"value":"0934-8387","type":"print"},{"value":"1438-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]}}}